Latest Breaking News On - Lester dearmond endowed chair - Page 1 : comparemela.com

Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors

Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesShivaani kummarCourtney flahertyKnight cancer instituteCancer researchDivision of hematology medical oncologyOregon health science university school of medicineLive on airLester dearmond endowed chairMedical oncologyOregon healthScience university schoolExperimental therapeuticsKnight cancerOnclive on airApple podcasts

Rezatapopt Revolutionizes Research Directions in TP53-Mutated Solid Tumors

Shivaani Kummar, MBBS, FACP, discusses the mechanism of action of the TP53-directed agent rezatapopt and efficacy data with this agent in solid tumors.

United statesSan diegoShivaani kummarDivision of hematology medical oncologyPharmaceuticals incCancer researchOregon health science university school of medicineInternational conference on molecularKnight cancer instituteLester dearmond endowed chairMedical oncologyOregon healthScience university schoolExperimental therapeuticsKnight cancerMolecular targets

Dr Kummar on the Evaluation of Rezatapopt in Advanced Solid Tumors

Shivaani Kummar, MD, FACP, discusses the evaluation of rezatapopt in patients with advanced solid tumors.

United statesShivaani kummarDivision of hematology medical oncologyOregon health science university school of medicineInternational conference on molecularKnight cancer instituteCancer researchDivision headLester dearmond endowed chairMedical oncologyOregon healthScience university schoolExperimental therapeuticsMolecular targetsCancer therapeuticsPatients with advanced solid tumors